Brain Tumor Panel

Home
Services
Brain Tumor Panel

Hospital Profile

Download Profile.PDF

Download Profile.DOC

IDH1 Mutation

Glioblastoma, the aggressive brain tumor is characterized by the wild-type Arginine residue at amino acid position 132. Tumors with any mutation changing the R132 to H, C, or S have been strongly associated with a better prognosis. Thus, WHO has recommended the test as the first test for classifying brain tumors.

Technique: ddPCR
TAT: 24 Hours

1P19Q Double Deletion

The tumor is classified as Oligodendroglioma if it has a mutated amino acid at position 132 and harbors the double deletion of 1p and 19q

Technique: FISH
TAT: 48 Hours TAT: 48 Hours

Integrated Head and Neck Oncology Program

Stem Cell Program

Molecular Immunology

Neuro-oncology Program

Gynaec-oncology Program

Product Research

Computational Biology

Advanced Diagnostic Research Center

Cancer Outreach Program

Technology Business Incubator

Brain Tumor Panel

Our Test

Hospital Profile

Book This Services

BRAIN TUMOR PANEL

IDH1 Mutation

1P19Q Double Deletion

Address:

Quick Links

LEAVE US A MESSAGE